Privia Health Group (NASDAQ:PRVA) Trading Down 5.2% – Time to Sell?

Shares of Privia Health Group, Inc. (NASDAQ:PRVAGet Free Report) traded down 5.2% during trading on Tuesday . The stock traded as low as $20.53 and last traded at $20.74. 139,032 shares traded hands during trading, a decline of 83% from the average session volume of 834,722 shares. The stock had previously closed at $21.87.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on PRVA shares. Truist Financial increased their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. JPMorgan Chase & Co. boosted their target price on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday, November 29th. Barclays raised their price target on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. Macquarie assumed coverage on shares of Privia Health Group in a research report on Monday. They set an “outperform” rating and a $25.00 price objective on the stock. Finally, Robert W. Baird upped their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, August 26th. Two research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $24.80.

Read Our Latest Stock Analysis on PRVA

Privia Health Group Trading Down 1.0 %

The company has a market cap of $2.42 billion, a PE ratio of 201.32, a P/E/G ratio of 5.45 and a beta of 0.83. The firm has a 50 day moving average of $20.19 and a two-hundred day moving average of $19.11.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Victory Capital Management Inc. lifted its position in Privia Health Group by 402.9% during the third quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock valued at $3,260,000 after purchasing an additional 143,446 shares during the period. GAMMA Investing LLC boosted its stake in shares of Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after buying an additional 845 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new stake in shares of Privia Health Group in the third quarter worth $1,206,000. Peregrine Capital Management LLC raised its holdings in Privia Health Group by 11.5% in the 2nd quarter. Peregrine Capital Management LLC now owns 314,190 shares of the company’s stock worth $5,461,000 after purchasing an additional 32,311 shares during the period. Finally, BlackBarn Capital Partners LP raised its position in shares of Privia Health Group by 100.0% during the 2nd quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company’s stock valued at $6,952,000 after purchasing an additional 200,000 shares during the period. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

(Get Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

See Also

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.